EMBC
Embecta Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.80
+1.93%Margins
Gross margin
59.9%
EBITDA margin
26.9%
EBIT margin
24.8%
Net margin
8.6%
FCF margin
16.2%
-14.3%
Return on equity
6.9%
Return on assets
28.5%
Return on invested capital
0.89x
Asset turnover
$174.1M
Cash from operations
$3.79
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026